Northern Trust Corp Pds Biotechnology Corp Transaction History

Northern Trust Corp

$658 Billion
Q1 2025

A detailed history of Northern Trust Corp transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Northern Trust Corp holds 82,532 shares of PDSB stock, worth $135,352. This represents 0.0% of its overall portfolio holdings.

Number of Shares

82,532

Previous 82,532 -0.0%

Holding current value

$135,352

Previous $134,000 26.87%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$1.63 - $4.11 $16,725 - $42,172	-10,261 Reduced 11.06%	82,532 $134,000
Q3 2024 Nov 13, 2024	SELL	$2.93 - $4.23 $431,679 - $623,210	-147,331 Reduced 61.36%	92,793 $354,000
Q2 2024 Aug 14, 2024	SELL	$2.55 - $4.02 $2,822 - $4,450	-1,107 Reduced 0.46%	240,124 $703,000
Q1 2024 May 14, 2024	SELL	$3.85 - $6.59 $32,567 - $55,744	-8,459 Reduced 3.39%	241,231 $955,000
Q4 2023 Feb 13, 2024	BUY	$3.95 - $6.58 $13,078 - $21,786	3,311 Added 1.34%	249,690 $1.24 Million
Q3 2023 Nov 13, 2023	BUY	$4.8 - $6.4 $39,504 - $52,672	8,230 Added 3.46%	246,379 $1.24 Million
Q2 2023 Aug 11, 2023	BUY	$5.03 - $9.9 $943,557 - $1.86 Million	187,586 Added 370.99%	238,149 $1.2 Million
Q1 2023 May 15, 2023	BUY	$5.68 - $11.99 $6,997 - $14,771	1,232 Added 2.5%	50,563 $310,000
Q4 2022 Feb 13, 2023	BUY	$3.28 - $13.2 $11,732 - $47,216	3,577 Added 7.82%	49,331 $651,000
Q3 2022 Nov 14, 2022	BUY	$2.97 - $5.79 $15,562 - $30,339	5,240 Added 12.93%	45,754 $136,000
Q2 2022 Aug 12, 2022	SELL	$3.05 - $6.68 $3,983 - $8,724	-1,306 Reduced 3.12%	40,514 $148,000
Q4 2021 Feb 08, 2022	BUY	$7.76 - $14.35 $19,136 - $35,387	2,466 Added 6.27%	41,820 $339,000
Q3 2021 Nov 15, 2021	BUY	$9.33 - $17.08 $28,559 - $52,281	3,061 Added 8.43%	39,354 $586,000
Q1 2021 May 12, 2021	SELL	$2.28 - $6.81 $27,642 - $82,564	-12,124 Reduced 25.04%	36,293 $165,000
Q4 2020 Feb 11, 2021	BUY	$1.91 - $2.67 $67,908 - $94,929	35,554 Added 276.41%	48,417 $103,000
Q3 2020 Nov 16, 2020	SELL	$1.67 - $4.67 $81 - $228	-49 Reduced 0.38%	12,863 $30,000
Q2 2020 Aug 14, 2020	BUY	$0.65 - $2.6 $941 - $3,767	1,449 Added 12.64%	12,912 $26,000
Q1 2020 May 14, 2020	BUY	$0.67 - $3.04 $7,680 - $34,847	11,463 New	11,463 $8,000

Others Institutions Holding PDSB

# of Institutions

Shares Held

8.24M

Call Options Held

151K

Put Options Held

1.2K

View Full List

About PDS Biotechnology Corp

Ticker PDSB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,458,700
Market Cap $46.7M
Description
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...

More about PDSB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Pds Biotechnology Corp Transaction History